Dyne Therapeutics, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:DYN) | MetaTrader

Open full chart

News

SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?

DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?

Dyne Therapeutics: A Buy, With Caveats, On DMD Progress (NASDAQ:DYN)

Dyne Therapeutics Trades Sideways Over An FDA Hurdle. Is It Time To Take Profits?

Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy

Dyne Therapeutics: 'Strong Buy' Due To Upcoming Z-Rostudirsen BLA Submission (DYN)

Dyne Stock Gains 10% on Initiation of Late-Stage Study in DMD Patients

Dyne Therapeutics (DYN) Upgraded to Buy: Here's What You Should Know

Jefferies reiterates Buy on BioMarin stock after DMD trial data

Micron and Palantir among market cap stock movers on Tuesday

Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)